MXPA04001034A - Compuestos para sanar heridas y en contra de envejecimiento. - Google Patents
Compuestos para sanar heridas y en contra de envejecimiento.Info
- Publication number
- MXPA04001034A MXPA04001034A MXPA04001034A MXPA04001034A MXPA04001034A MX PA04001034 A MXPA04001034 A MX PA04001034A MX PA04001034 A MXPA04001034 A MX PA04001034A MX PA04001034 A MXPA04001034 A MX PA04001034A MX PA04001034 A MXPA04001034 A MX PA04001034A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- aging
- wound healing
- development
- matrix metalloproteinases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Abstract
La invencion proporciona inhibidores de metaloproteinaseas de matriz que son utiles para alentar el desarrollo de una piel saludable y para tratar las heridas. Los inhibidores son peptidos que tienen secuencias relacionadas a las regiones de desdoblamiento de las formas de proenzima de metaloproteinaseas de matriz. Los inhibidores de peptido de la invencion pueden ser formulados en composiciones terapeuticas, lociones, cremas, vendajes para heridas y coberturas de la piel que facilitan la curacion y el desarrollo de piel saludable, desalientan las cicatrices y las arrugas y mejoran los efectos de la curacion.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31272601P | 2001-08-16 | 2001-08-16 | |
US10/032,376 US7186693B2 (en) | 2001-08-16 | 2001-12-21 | Metalloproteinase inhibitors for wound healing |
US10/153,185 US6906036B2 (en) | 2001-08-16 | 2002-05-21 | Anti-aging and wound healing compounds |
PCT/US2002/026198 WO2003016520A1 (en) | 2001-08-16 | 2002-08-15 | Anti-aging and wound healing compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04001034A true MXPA04001034A (es) | 2004-05-27 |
Family
ID=46150134
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04001034A MXPA04001034A (es) | 2001-08-16 | 2002-08-15 | Compuestos para sanar heridas y en contra de envejecimiento. |
MXPA04001033A MXPA04001033A (es) | 2001-08-16 | 2002-08-15 | Compuesto de sanado para heridas y anti-cancer. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04001033A MXPA04001033A (es) | 2001-08-16 | 2002-08-15 | Compuesto de sanado para heridas y anti-cancer. |
Country Status (9)
Country | Link |
---|---|
US (2) | US6906036B2 (es) |
EP (2) | EP1423515A4 (es) |
KR (4) | KR20040023708A (es) |
CN (2) | CN1549722A (es) |
AU (1) | AU2002324737A1 (es) |
BR (1) | BR0211641A (es) |
CA (2) | CA2456158A1 (es) |
MX (2) | MXPA04001034A (es) |
WO (2) | WO2003018748A2 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
US7094754B2 (en) * | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7071164B2 (en) * | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7517857B2 (en) * | 2002-01-29 | 2009-04-14 | Posco | Immune-modulating peptide |
AU2003257089A1 (en) * | 2002-07-31 | 2004-02-16 | University Of Florida | Antimicrobial and antiproteolytic wound dressing |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
EP1648493B1 (en) * | 2003-07-07 | 2009-12-09 | Van Andel Research Institute | Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
US8758313B2 (en) | 2003-10-28 | 2014-06-24 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
GB0325120D0 (en) * | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
GB0518804D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Exudialysis tissue cleanser |
JP4815752B2 (ja) | 2004-04-01 | 2011-11-16 | 味の素株式会社 | アミノ酸含有飲食品 |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10413644B2 (en) | 2004-04-27 | 2019-09-17 | Smith & Nephew Plc | Wound treatment apparatus and method |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
WO2007027849A2 (en) * | 2005-08-31 | 2007-03-08 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
DE602005020047D1 (de) * | 2005-09-05 | 2010-04-29 | Immatics Biotechnologies Gmbh | Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden |
US7645583B2 (en) | 2005-12-14 | 2010-01-12 | Kimberly-Clark Worldwide, Inc. | Identification of compounds for inhibiting complexation of C-reactive protein with fibronectin |
US20070264354A1 (en) * | 2006-05-09 | 2007-11-15 | Herman Richard M | Treatment of a wound with a vasodilator |
EP2623132B1 (en) | 2007-07-18 | 2016-03-30 | The Board of Trustees of the University of Illionis | Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
US8987212B2 (en) | 2007-08-07 | 2015-03-24 | Muhammed Majeed | Oleanoyl peptide composition and method of treating skin aging |
ES2330291B1 (es) * | 2008-02-29 | 2010-10-18 | Lipotec Sa | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
US8716438B2 (en) | 2009-10-09 | 2014-05-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Matricryptic ECM peptides for tissue reconstruction |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
WO2017120461A1 (en) | 2016-01-08 | 2017-07-13 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US8435541B2 (en) | 2010-09-02 | 2013-05-07 | Bath & Body Works Brand Management, Inc. | Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities |
HUE027470T2 (en) * | 2010-09-17 | 2016-09-28 | Abbell Ab | Treatment of fungal infections |
US10279007B2 (en) | 2010-11-15 | 2019-05-07 | Oxygenetix Institute, Inc. | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs |
WO2016126343A1 (en) | 2015-02-05 | 2016-08-11 | Muhammed Majeed | Oleanoyl peptide composition and collagen enhancement |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
WO2014100779A1 (en) | 2012-12-21 | 2014-06-26 | Advanced Cell Technology, Inc. | Methods ofr production of platelets from pluripotent stem cells and compositions thereof |
AU2014266943B2 (en) | 2013-05-10 | 2018-03-01 | Smith & Nephew Plc | Fluidic connector for irrigation and aspiration of wounds |
WO2015088915A1 (en) | 2013-12-09 | 2015-06-18 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
CN105477627B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 治疗前列腺癌的组合物及其用途 |
CN105412916B (zh) * | 2014-09-19 | 2021-04-30 | 达森生物药业有限公司 | 治疗乳腺癌的组合物及其用途 |
CN105477628B (zh) * | 2014-09-19 | 2021-04-30 | 山东蓝金生物工程有限公司 | 抗癌组合物及其用途 |
KR101744959B1 (ko) | 2014-12-05 | 2017-06-12 | (주)케어젠 | 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
SI3307296T1 (sl) | 2015-06-15 | 2022-04-29 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel | TIMP2 za uporabo pri zdravljenju s starostjo povezanih stanj |
JP7337695B2 (ja) | 2017-01-27 | 2023-09-04 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
KR102007078B1 (ko) | 2017-03-24 | 2019-08-05 | (주)셀아이콘랩 | 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물 |
EP3703636A1 (en) * | 2017-11-03 | 2020-09-09 | Systagenix Wound Management, Limited | Nutrient-enriched dressing |
KR102087044B1 (ko) * | 2018-04-30 | 2020-03-10 | 인하대학교 산학협력단 | Mmp-10 또는 이를 코딩하는 유전자의 발현을 억제하는 제제를 포함하는 암 전이 억제용 조성물 |
CZ308845B6 (cs) * | 2019-01-21 | 2021-07-07 | Globetech Innovation S.R.O | Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran |
CN111632127B (zh) * | 2019-02-14 | 2022-07-05 | 三凡生技研发股份有限公司 | 短链胜肽组合物及其于皮肤保护的用途 |
CN111748041B (zh) * | 2019-03-11 | 2021-09-14 | 中国科学院苏州纳米技术与纳米仿生研究所 | 微环境控释型功能化水凝胶、其制备方法及应用 |
CN113307851B (zh) * | 2021-06-11 | 2022-04-29 | 珠海医美企业管理有限公司 | 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用 |
CN113698452B (zh) * | 2021-08-23 | 2023-08-18 | 四川丽妍工坊生物科技有限公司 | 一种促皮肤修复肽、制备方法及其应用 |
WO2023080578A1 (ko) * | 2021-11-05 | 2023-05-11 | 주식회사 레메디 | 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도 |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2507379A1 (fr) * | 1981-06-05 | 1982-12-10 | Europ Composants Electron | Bloc de condensateurs en serie et multiplicateur de tension utilisant un tel bloc de condensateurs |
US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
US5270447A (en) * | 1988-05-20 | 1993-12-14 | The United States Of America As Represented By The Department Of Health & Human Services | Metalloproteinase peptides: role in diagnosis and therapy |
US5698671A (en) * | 1989-03-21 | 1997-12-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Metalloproteinase peptides |
EP0513209A4 (en) * | 1990-01-26 | 1993-08-25 | Us Commerce | A method for quantitatively measuring collagenase |
WO1994010208A1 (en) | 1992-10-29 | 1994-05-11 | Miles Inc. | Diagnostic assay for latent matrix metalloproteinase no. 9 |
JP3098640B2 (ja) | 1992-12-24 | 2000-10-16 | 富士薬品工業株式会社 | ヒト72−kDaゼラチナーゼ/IV型コラゲナーゼの免疫学的定量法 |
JP2673929B2 (ja) | 1993-04-12 | 1997-11-05 | 富士薬品工業株式会社 | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
US6150152A (en) * | 1993-05-28 | 2000-11-21 | Washington University | Human macrophage metalloelastase |
AU7128494A (en) * | 1993-07-09 | 1995-02-06 | Celltech Limited | Gelatinase antagonists used for treating cancer |
JPH07303482A (ja) | 1993-11-30 | 1995-11-21 | Fuji Yakuhin Kogyo Kk | 新規なメタロプロテアーゼおよびそれをコードするdna |
JPH07159402A (ja) | 1993-12-09 | 1995-06-23 | Kyodo Nyugyo Kk | Iv型コラゲナ−ゼ測定法 |
JPH07330795A (ja) * | 1994-06-07 | 1995-12-19 | Toagosei Co Ltd | ペプチドおよびモノクローナル抗体 |
DE69528614T2 (de) * | 1994-07-07 | 2003-06-18 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft | Modifizierte Proenzyme als Substrate für proteolische Enzyme |
DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
JPH08134098A (ja) | 1994-11-11 | 1996-05-28 | Morinaga & Co Ltd | ヒトtimp−1の高感度測定法 |
JPH08136548A (ja) | 1994-11-11 | 1996-05-31 | Morinaga & Co Ltd | 泌尿器癌の診断法 |
JPH10510986A (ja) | 1994-12-13 | 1998-10-27 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | メタロプロテイナーゼ−4のヒト組織インヒビター |
JP2949467B2 (ja) | 1995-02-16 | 1999-09-13 | 富士薬品工業株式会社 | 免疫学的測定法によるヒトプロマトリックスメタロプロテアーゼ7の定量 |
US5770691A (en) * | 1995-06-05 | 1998-06-23 | Regents Of The University Of Minnesota | Discriminatory substrates for MMP hydrolysis |
JPH0987299A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | Mmp−2活性化因子に特異的なモノクローナル抗体 |
US6191255B1 (en) * | 1995-07-14 | 2001-02-20 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Protein and monoclonal antibody specific thereto |
JPH0984589A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
IT1277904B1 (it) | 1995-08-07 | 1997-11-12 | Polifarma Spa | Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego |
DE69725901T2 (de) | 1996-01-04 | 2004-09-09 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Methode zur bestimmung von proteolytischen enzymen unter benutzung von fluoreszenzgelöschten substraten |
JPH09206099A (ja) | 1996-01-31 | 1997-08-12 | Sekisui Chem Co Ltd | 細胞機能測定方法 |
GB9615976D0 (en) | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
US6022948A (en) | 1996-09-17 | 2000-02-08 | Washington University | Method of cell surface activation and inhibition |
ATE290878T1 (de) * | 1996-12-06 | 2005-04-15 | Fonden Til Fremme Af Eksperime | Inhibierung von invasiver remodulierung |
WO1998031818A2 (en) | 1997-01-21 | 1998-07-23 | Human Genome Sciences, Inc. | Tace-like and matrilysin-like polypeptides |
JPH10210982A (ja) | 1997-01-31 | 1998-08-11 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
EP0972071A4 (en) * | 1997-03-07 | 2004-04-21 | Tropix Inc | TEST ARRANGEMENT FOR PROTEAS INHIBITORS |
WO1998040475A1 (en) | 1997-03-11 | 1998-09-17 | Abbott Laboratories | Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same |
US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
AUPO573697A0 (en) | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
JPH10287700A (ja) | 1997-04-10 | 1998-10-27 | Fuji Yakuhin Kogyo Kk | 活性型マトリライシン(mmp−7)に対する抗体及びそれを用いた免疫学的測定法 |
JPH10313896A (ja) | 1997-05-15 | 1998-12-02 | Yamanouchi Pharmaceut Co Ltd | マトリックスメタロプロテアーゼに対する発色団又は蛍光団を有する新規な活性測定用合成基質 |
US6043087A (en) | 1997-07-25 | 2000-03-28 | The New York Blood Center | Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
US6034864A (en) | 1997-11-14 | 2000-03-07 | Murata Manufacturing Co., Ltd. | Multilayer capacitor |
KR100558288B1 (ko) | 1997-12-19 | 2006-03-10 | 와이어쓰 | 연골의 퇴행성 질환용 트랜스제닉 동물 모델 |
FI980604A0 (fi) * | 1998-03-18 | 1998-03-18 | Univ Helsinki Licensing | Nya matrismetalloproteinasinhibitorer och -regulatorer |
WO1999058126A1 (en) | 1998-05-11 | 1999-11-18 | The Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
WO1999065519A1 (en) * | 1998-06-16 | 1999-12-23 | The General Hospital Corporation | Matrix metalloproteinase proenzyme activator |
US6191225B1 (en) * | 1998-08-31 | 2001-02-20 | Ppg Industries Ohio, Inc. | Thermosetting compositions containing carboxylic acid functional polymers and epoxy functional polymers prepared by atom transfer radical polymerization |
JP2002526772A (ja) | 1998-10-08 | 2002-08-20 | カルバイオケム ノババイオケム コーポレイション | マトリックスメタロプロテイナーゼ9の診断アッセイおよびその使用 |
CA2347136A1 (en) * | 1998-10-16 | 2000-04-27 | Otsuka Pharmaceutical Co., Ltd. | Neovascular-specific peptides |
USH1973H1 (en) | 1998-10-22 | 2001-07-03 | Novartis Ag | Human neutrophil collagenase splice variant |
AU776473C (en) * | 1999-03-11 | 2005-04-14 | Entremed, Inc | Compositions and methods for treating cancer and hyperproliferative disorders |
JP2000270874A (ja) | 1999-03-25 | 2000-10-03 | Fuji Chemical Industries Ltd | 新規な膜結合型メタロプロテアーゼ |
US6274717B1 (en) | 1999-04-20 | 2001-08-14 | Smithkline Beecham Corporation | Splicing variant of human membrane-type matrix metalloproteinease-5 (MT-MMP5-L) |
CA2377385A1 (en) | 1999-06-03 | 2000-12-14 | Jessie L.S. Au | Methods and compositions for modulating cell proliferation and cell death |
JP2001072589A (ja) * | 1999-07-06 | 2001-03-21 | Toagosei Co Ltd | 制癌剤 |
KR100509119B1 (ko) * | 1999-07-16 | 2005-08-18 | 주식회사 엘지생활건강 | 프로시아니딘 올리고머를 유효성분으로 하는 약제 |
US6403637B1 (en) | 1999-08-09 | 2002-06-11 | Univ Saint Louis | Methods of modulating matrix metalloproteinase activity and uses thereof |
CA2383562A1 (en) * | 1999-08-26 | 2001-03-01 | Keith M. Skubitz | Peptides capable of modulating the function of cd66 (ceacam) family members |
GB9927576D0 (en) | 1999-11-23 | 2000-01-19 | Univ Birmingham | Novel assay |
US20020063763A1 (en) * | 2000-11-29 | 2002-05-30 | Mantell David Allen | Apparatus and method for removing air bubbles from an ink jet printhead |
US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
US20030054985A1 (en) | 2000-02-22 | 2003-03-20 | Stuart Aaronson | N-cadherin modulated migration, invasion, and metastasis |
GB0004531D0 (en) | 2000-02-25 | 2000-04-19 | Richards Andrew J M | The treatment of respiratory diseases |
US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
US7071164B2 (en) * | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
US7094754B2 (en) * | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
-
2002
- 2002-05-21 US US10/153,185 patent/US6906036B2/en not_active Expired - Lifetime
- 2002-08-15 CN CNA028151356A patent/CN1549722A/zh active Pending
- 2002-08-15 CA CA002456158A patent/CA2456158A1/en not_active Abandoned
- 2002-08-15 KR KR10-2004-7001607A patent/KR20040023708A/ko active Search and Examination
- 2002-08-15 WO PCT/US2002/026319 patent/WO2003018748A2/en active Application Filing
- 2002-08-15 AU AU2002324737A patent/AU2002324737A1/en not_active Abandoned
- 2002-08-15 WO PCT/US2002/026198 patent/WO2003016520A1/en active Application Filing
- 2002-08-15 BR BR0211641-3A patent/BR0211641A/pt not_active IP Right Cessation
- 2002-08-15 MX MXPA04001034A patent/MXPA04001034A/es active IP Right Grant
- 2002-08-15 EP EP02759388A patent/EP1423515A4/en not_active Withdrawn
- 2002-08-15 CN CN028151348A patent/CN1543503B/zh not_active Expired - Fee Related
- 2002-08-15 CA CA002455883A patent/CA2455883A1/en not_active Abandoned
- 2002-08-15 KR KR10-2004-7001667A patent/KR20040028974A/ko not_active Application Discontinuation
- 2002-08-15 MX MXPA04001033A patent/MXPA04001033A/es unknown
- 2002-08-15 KR KR1020097009201A patent/KR100944318B1/ko active IP Right Grant
- 2002-08-15 KR KR1020107002153A patent/KR100996047B1/ko active IP Right Grant
- 2002-08-15 EP EP02759399A patent/EP1513542A4/en not_active Withdrawn
-
2005
- 2005-01-07 US US11/031,488 patent/US7196162B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR20100018107A (ko) | 2010-02-16 |
KR100996047B1 (ko) | 2010-11-22 |
CA2456158A1 (en) | 2003-02-27 |
CN1543503A (zh) | 2004-11-03 |
EP1513542A2 (en) | 2005-03-16 |
EP1423515A4 (en) | 2008-02-27 |
US20050239710A1 (en) | 2005-10-27 |
US6906036B2 (en) | 2005-06-14 |
US20030148959A1 (en) | 2003-08-07 |
EP1423515A1 (en) | 2004-06-02 |
MXPA04001033A (es) | 2004-05-27 |
WO2003018748A3 (en) | 2004-05-27 |
CA2455883A1 (en) | 2003-03-06 |
WO2003016520A1 (en) | 2003-02-27 |
KR20040023708A (ko) | 2004-03-18 |
KR20090051781A (ko) | 2009-05-22 |
KR20040028974A (ko) | 2004-04-03 |
US7196162B2 (en) | 2007-03-27 |
BR0211641A (pt) | 2004-07-13 |
CN1543503B (zh) | 2011-06-15 |
WO2003018748A2 (en) | 2003-03-06 |
AU2002324737A1 (en) | 2003-03-10 |
KR100944318B1 (ko) | 2010-03-03 |
EP1513542A4 (en) | 2009-07-15 |
CN1549722A (zh) | 2004-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04001034A (es) | Compuestos para sanar heridas y en contra de envejecimiento. | |
DE60138549D1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
WO2003106381A3 (en) | ADAM 10 HUMAN INHIBITORS | |
CY1108633T1 (el) | Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου | |
HUP0300135A3 (en) | Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails | |
AU2001246484A1 (en) | Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
IL166016A0 (en) | Topical treatment of skin diseases | |
UA88175C2 (ru) | Способ косметической обработки стареющей кожи при помощи местного применения композиции, которая содержит циклогексанмоно-, -ди- или -триолы или циклогексилметан- или -этан-, или -пропанолы | |
EP1578780A4 (en) | PROCESS FOR INCREASING FIBRONECTIN | |
MXPA03011622A (es) | Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas. | |
AU2002231087A1 (en) | Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases | |
AU2003270625A8 (en) | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing | |
IL138594A0 (en) | Use of protease inhibitors for treating skin wounds | |
GB0217136D0 (en) | Wound healing & treatment of fibrosis | |
YU31104A (sh) | Inhibicija virusa n-dokozanolom | |
AU3934000A (en) | Inhibitors of endothelin-1 synthesis | |
ID26965A (id) | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid | |
YU76403A (sh) | Sintetski peptidi i postupak za preventivnu i terapeutsku upotrebu kod širenja kancera i metastaza | |
EP1330271A4 (en) | USE OF TRANSCRIPTION FACTORS FOR THE TREATMENT OF INFLAMMATION AND OTHER DISEASES | |
AU2001291604A1 (en) | Use of proton pump inhibitors for treating diseases of the locomotor system | |
BR0314364A (pt) | Uso de inibidores de pde iv para tratar angiogênese | |
DE60006284D1 (de) | Arzneimittel zur behandlung konvulsivischer zustände | |
AU2002224905A1 (en) | Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |